Prediction of suicide death using EHR and polygenic risk scores
Prediction of suicide death using EHR and polygenic risk scores
批准号:
10659155
负责人:
Hilary Coon
金额:
$68.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-15 至 2025-06-30
关键词:
AccidentsAccountingAddressAgeAnxietyAreaAwardCause of DeathClassificationCodeCohort StudiesCollaborationsCollectionDNADataData ElementDevelopmentDiagnosticDiscriminationDocumentationElectronic Health RecordElementsFeeling suicidalFutureGeneticGenetic RiskGenotypeGroupingHandHealthcareHealthcare SystemsIncidenceIndividualInterventionKnowledgeMajor Depressive DisorderMeasuresMedical ExaminersMental disordersModelingMolecularNatural Language ProcessingParticipantPharmaceutical PreparationsPhenotypePhysiciansPopulationPopulation ControlPreventionResourcesRiskSamplingSubstance Use DisorderSuicideSuicide attemptTestingTraumaUniversitiesUtahValidationWorkbiobankcohortcomparison groupdata resourcedemographicsdeprivationeHealthearly life stressenvironmental stressorgenome-widehigh risk populationimprovedindexinglarge datasetsmachine learning methodmachine learning predictionmedical schoolsmodel developmentpolygenic risk scorepopulation basedpredictive modelingsample collectionsexsocioeconomicssuicidalsuicidal behaviorsuicidal morbiditysuicidal risk
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Suicide is a leading cause of death that continues to increase, with over 47,000 preventable suicide deaths per
year in the U.S. Although we have made great strides in using electronic health records (EHR) and other
factors to predict suicidal ideation and behavior, our ability to reliably predict suicide death is close to zero.
From a healthcare standpoint, predicting suicide deaths is tricky. We know that the incidence of suicide
behaviors is far more common (~4%-5% per year) compared to suicide death (~0.01%-0.02% per year).
Essentially, only a small fraction of those who engage in suicidal behaviors will go on to die by suicide.
Knowledge of who these highest risk individuals are is critically important in directing prevention efforts and
development of future targeted interventions. In addition, well over half of suicide deaths occur with no prior
attempts, even accounting for lack of documentation of attempts in diagnostic codes. These “out of the blue”
cases suggest one or more high-risk groups even more elusive to accurate prediction and prevention.
Including genetic data of suicide deaths may offer substantial predictive improvement; genetic factors account
for close to 50% of the risk of suicide death. Using the extensive genetic data, statewide longitudinal EHR
resources, demographic, and familial data available to the Utah Suicide Genetic Risk Study (USGRS), we are
uniquely poised to address this critical knowledge gap. Our primary focus will be to use machine learning
methods develop models that predict suicide deaths. In addition, our large suicide death research resource will
also allow us to model differences of suicide deaths with vs. without prior attempts. Of the ~9,000 Utah suicide
deaths with demographics and environmental data, familial data, and 2 decades of longitudinal EHR data, the
USGRS also currently has DNA from >6,000, which will increase to ~10,000 during the award period. Genome-
wide molecular data is in hand for over 5,000 of these Utah suicides, allowing for tests of association of suicide
subtypes identified using EHR data with “genetic phenotypes” represented by polygenic risk scores. The
USGRS also has demographics, familial data, and longitudinal EHR data from 5 age/sex- matched Utah
population controls for each suicide death, allowing for comparisons of non-lethal attempts to suicide deaths. In
addition, we will collaborate with colleagues at the Mount Sinai School of Medicine, who are currently
developing EHR and polygenic risk models to study substance use disorder, anxiety, and major depressive
disorder in 37,510 participants in the Mount Sinai BioMe Biorepository. They will expand this work to include
suicidality to provide an additional resource of suicide attempt for our model development and testing. We will
additionally study polygenic risk scores associated with suicide death vs. attempt using our resources, Mount
Sinai BioMe, and a collaboration with Vanderbilt University for access to their Biobank and to suicide attempts
in the UK Biobank.. Independent validation will be possible through genotyping of new Utah suicides collected
throughout the project, with additional comparisons to attempt cases in large datasets available through the
PsychEMERGE consortium.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Rare Copy Number Variation in Schizophrenia and Implications for Treatment.
精神分裂症的罕见拷贝数变异及其治疗意义。
DOI:
10.1093/schbul/sbad028
发表时间:
2023
期刊:
Schizophrenia bulletin
影响因子:
6.6
作者:
[Docherty,AnnaR]
通讯作者:
Docherty,AnnaR
DOI:
10.1016/j.biopsych.2019.10.014
发表时间:
2020-03-01
期刊:
BIOLOGICAL PSYCHIATRY
影响因子:
10.6
作者:
[Chan, Robin F., Turecki, Gustavo, Shabalin, Andrey A., Guintivano, Jerry, Zhao, Min, Xie, Lin Y., van Grootheest, Gerard, Kaminsky, Zachary A., Dean, Brian, Penninx, Brenda W. J. H., Aberg, Karolina A., van den Oord, Edwin J. C. G.]
通讯作者:
van den Oord, Edwin J. C. G.
DOI:
10.1371/journal.pone.0282271
发表时间:
2023
期刊:
PLOS ONE
影响因子:
3.7
作者:
[Waszczuk, Monika A., Morozova, Olga, Lhuillier, Elizabeth, Docherty, Anna R., Shabalin, Andrey A., Yang, Xiaohua, Carr, Melissa A., Clouston, Sean A. P., Kotov, Roman, Luft, Benjamin J.]
通讯作者:
Luft, Benjamin J.
Genetics and epigenetics of self-injurious thoughts and behaviors: Systematic review of the suicide literature and methodological considerations.
自我伤害思想和行为的遗传学和表观遗传学:自杀文献和方法论上的系统评价。
DOI:
10.1002/ajmg.b.32917
发表时间:
2022-10
期刊:
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
影响因子:
2.8
作者:
[Mirza, Salahudeen, Docherty, Anna R., Bakian, Amanda, Coon, Hilary, Soares, Jair C., Walss-Bass, Consuelo, Fries, Gabriel R.]
通讯作者:
Fries, Gabriel R.
DOI:
10.1016/j.biopsych.2021.05.029
发表时间:
2022-02-01
期刊:
Biological psychiatry
影响因子:
10.6
作者:
[Mullins N, Kang J, Campos AI, Coleman JRI, Edwards AC, Galfalvy H, Levey DF, Lori A, Shabalin A, Starnawska A, Su MH, Watson HJ, Adams M, Awasthi S, Gandal M, Hafferty JD, Hishimoto A, Kim M, Okazaki S, Otsuka I, Ripke S, Ware EB, Bergen AW, Berrettini WH, Bohus M, Brandt H, Chang X, Chen WJ, Chen HC, Crawford S, Crow S, DiBlasi E, Duriez P, Fernández-Aranda F, Fichter MM, Gallinger S, Glatt SJ, Gorwood P, Guo Y, Hakonarson H, Halmi KA, Hwu HG, Jain S, Jamain S, Jiménez-Murcia S, Johnson C, Kaplan AS, Kaye WH, Keel PK, Kennedy JL, Klump KL, Li D, Liao SC, Lieb K, Lilenfeld L, Liu CM, Magistretti PJ, Marshall CR, Mitchell JE, Monson ET, Myers RM, Pinto D, Powers A, Ramoz N, Roepke S, Rozanov V, Scherer SW, Schmahl C, Sokolowski M, Strober M, Thornton LM, Treasure J, Tsuang MT, Witt SH, Woodside DB, Yilmaz Z, Zillich L, Adolfsson R, Agartz I, Air TM, Alda M, Alfredsson L, Andreassen OA, Anjorin A, Appadurai V, Soler Artigas M, Van der Auwera S, Azevedo MH, Bass N, Bau CHD, Baune BT, Bellivier F, Berger K, Biernacka JM, Bigdeli TB, Binder EB, Boehnke M, Boks MP, Bosch R, Braff DL, Bryant R, Budde M, Byrne EM, Cahn W, Casas M, Castelao E, Cervilla JA, Chaumette B, Cichon S, Corvin A, Craddock N, Craig D, Degenhardt F, Djurovic S, Edenberg HJ, Fanous AH, Foo JC, Forstner AJ, Frye M, Fullerton JM, Gatt JM, Gejman PV, Giegling I, Grabe HJ, Green MJ, Grevet EH, Grigoroiu-Serbanescu M, Gutierrez B, Guzman-Parra J, Hamilton SP, Hamshere ML, Hartmann A, Hauser J, Heilmann-Heimbach S, Hoffmann P, Ising M, Jones I, Jones LA, Jonsson L, Kahn RS, Kelsoe JR, Kendler KS, Kloiber S, Koenen KC, Kogevinas M, Konte B, Krebs MO, Landén M, Lawrence J, Leboyer M, Lee PH, Levinson DF, Liao C, Lissowska J, Lucae S, Mayoral F, McElroy SL, McGrath P, McGuffin P, McQuillin A, Medland SE, Mehta D, Melle I, Milaneschi Y, Mitchell PB, Molina E, Morken G, Mortensen PB, Müller-Myhsok B, Nievergelt C, Nimgaonkar V, Nöthen MM, O'Donovan MC, Ophoff RA, Owen MJ, Pato C, Pato MT, Penninx BWJH, Pimm J, Pistis G, Potash JB, Power RA, Preisig M, Quested D, Ramos-Quiroga JA, Reif A, Ribasés M, Richarte V, Rietschel M, Rivera M, Roberts A, Roberts G, Rouleau GA, Rovaris DL, Rujescu D, Sánchez-Mora C, Sanders AR, Schofield PR, Schulze TG, Scott LJ, Serretti A, Shi J, Shyn SI, Sirignano L, Sklar P, Smeland OB, Smoller JW, Sonuga-Barke EJS, Spalletta G, Strauss JS, Świątkowska B, Trzaskowski M, Turecki G, Vilar-Ribó L, Vincent JB, Völzke H, Walters JTR, Shannon Weickert C, Weickert TW, Weissman MM, Williams LM, Wray NR, Zai CC, Ashley-Koch AE, Beckham JC, Hauser ER, Hauser MA, Kimbrel NA, Lindquist JH, McMahon B, Oslin DW, Qin X, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Eating Disorders Working Group of the Psychiatric Genomics Consortium, German Borderline Genomics Consortium, MVP Suicide Exemplar Workgroup, VA Million Veteran Program, Agerbo E, Børglum AD, Breen G, Erlangsen A, Esko T, Gelernter J, Hougaard DM, Kessler RC, Kranzler HR, Li QS, Martin NG, McIntosh AM, Mors O, Nordentoft M, Olsen CM, Porteous D, Ursano RJ, Wasserman D, Werge T, Whiteman DC, Bulik CM, Coon H, Demontis D, Docherty AR, Kuo PH, Lewis CM, Mann JJ, Rentería ME, Smith DJ, Stahl EA, Stein MB, Streit F, Willour V, Ruderfer DM]
通讯作者:
Ruderfer DM
共 13 条
Prediction of suicide death using EHR and polygenic risk scores
-
批准号:10451573
-
项目类别:
-
资助金额:$68.9万
-
财政年份:2020
-
负责人:Hilary Coon
-
依托单位:
Prediction of suicide death using EHR and polygenic risk scores
-
批准号:10239191
-
项目类别:
-
资助金额:$68.9万
-
财政年份:2020
-
负责人:Hilary Coon
-
依托单位:
Genetic risk discovery using WGS from a population-based resource of 10,000 suicide deaths with DNA
-
批准号:10553712
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2020
-
负责人:Hilary Coon
-
依托单位:
Prediction of suicide death using EHR and polygenic risk scores
-
批准号:10027263
-
项目类别:
-
资助金额:$73.83万
-
财政年份:2020
-
负责人:Hilary Coon
-
依托单位:
Genetic risk discovery using WGS from a population-based resource of 10,000 suicide deaths with DNA
-
批准号:10337286
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2020
-
负责人:Hilary Coon
-
依托单位:
Genetic analysis of high-risk Utah suicide pedigrees
-
批准号:9114177
-
项目类别:
-
资助金额:$83.55万
-
财政年份:2013
-
负责人:Hilary Coon
-
依托单位:
Genetic analysis of high-risk Utah suicide pedigrees
-
批准号:8850718
-
项目类别:
-
资助金额:$67.01万
-
财政年份:2013
-
负责人:Hilary Coon
-
依托单位:
Genetic analysis of high-risk Utah suicide pedigrees
-
批准号:9033440
-
项目类别:
-
资助金额:$15.53万
-
财政年份:2013
-
负责人:Hilary Coon
-
依托单位:
Genetic analysis of high-risk Utah suicide pedigrees
-
批准号:9275545
-
项目类别:
-
资助金额:$82.83万
-
财政年份:2013
-
负责人:Hilary Coon
-
依托单位:
Genetic analysis of high-risk Utah suicide pedigrees
-
批准号:8575486
-
项目类别:
-
资助金额:$74.19万
-
财政年份:2013
-
负责人:Hilary Coon
-
依托单位:
1/3 - Sequencing Autism Spectrum Disorder Extended Pedigrees
-
批准号:8472363
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2012
-
负责人:Hilary Coon
-
依托单位:
1/3 - Sequencing Autism Spectrum Disorder Extended Pedigrees
-
批准号:8659503
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2012
-
负责人:Hilary Coon
-
依托单位:
1/3 - Sequencing Autism Spectrum Disorder Extended Pedigrees
-
批准号:8292544
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2012
-
负责人:Hilary Coon
-
依托单位:
Genetics of Autism Intermediate Phenotypes
-
批准号:6916643
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2005
-
负责人:Hilary Coon
-
依托单位:
Genetics of Autism Intermediate Phenotypes
-
批准号:7254885
-
项目类别:
-
资助金额:$40.8万
-
财政年份:2005
-
负责人:Hilary Coon
-
依托单位:
Genetics of Autism Intermediate Phenotypes
-
批准号:7121063
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2005
-
负责人:Hilary Coon
-
依托单位:
Genetics of Autism Intermediate Phenotypes
-
批准号:7647056
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2005
-
负责人:Hilary Coon
-
依托单位:
Genetics of Autism Intermediate Phenotypes
-
批准号:7446821
-
项目类别:
-
资助金额:$49.93万
-
财政年份:2005
-
负责人:Hilary Coon
-
依托单位:
CORE--BIOSTATISTICS
-
批准号:6494823
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2001
-
负责人:Hilary Coon
-
依托单位:
CORE--BIOSTATISTICS
-
批准号:6353041
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2000
-
负责人:Hilary Coon
-
依托单位:
海外基金